RUA Life Sciences (LON:RUA) Announces Quarterly Earnings Results

Posted by on Jun 30th, 2026

RUA Life Sciences (LON:RUA – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX (0.33) earnings per share (EPS) for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

RUA Life Sciences Stock Performance

RUA stock remained flat at GBX 19 during trading on Friday. The company had a trading volume of 164,275 shares, compared to its average volume of 239,799. RUA Life Sciences has a fifty-two week low of GBX 10.42 and a fifty-two week high of GBX 26.80. The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32. The firm has a market capitalization of £11.79 million, a P/E ratio of -2.61 and a beta of 0.95. The business’s fifty day simple moving average is GBX 19.98 and its 200 day simple moving average is GBX 16.02.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Featured Articles

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.